Wolters Kluwer divides lead role

Wolters Kluwer Pharma Solutions appointed Bob Jansen and Michelle Woker as co-presidents of its analytics business.
Jansen and Woker will lead the commercial and operations functions, respectively. Their promotions follow the retirement of former Wolters Kluwer Pharma Solutions head Mark Spiers in April. Bob Becker, head of parent company Wolters Kluwer Health & Pharma Solutions, had been running the unit in the interim. The new leaders will report directly to him.
Jansen had been SVP, commercial operations, for Wolters Kluwer Pharma Solutions' healthcare analytics business since 2007. Prior to that, he had helped lead managed markets sales and contracting areas for a number of pharmaceutical companies. Woker has been with the healthcare analytics business for 17 years, most recently as SVP, operations.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.